SLEEP Meeting 2025 Recap
Wake Up Narcolepsy (WUN) representatives are always excited to attend the annual SLEEP Meeting hosted......
Wake Up Narcolepsy is a 501(c)(3) not for profit organization that seeks to raise awareness, bringing direction to the search for a cure while providing a strong community of support. Stay current and connect with WUN.
Narcolepsy by the Numbers
2000
Narcolepsy affects 1 in every 2,000 Americans and 3 million people worldwide.
50
It is estimated that up to 50% of patients with Narcolepsy may be undiagnosed.
20
Typical onset of Narcolepsy is between the ages of 10 and 20 years old, but can occur in early childhood.
6
On average, patients have 6 physician visits before receiving a Narcolepsy diagnosis.
Latest News
-
-
Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Jun. 11, 2025– Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the presentat...
-
Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025
DUBLIN, June 9, 2025 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced late-breaking Phase 4 data evaluating treatment bene...
-
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicine...
Finding a cure quicker, together.
Partnering with our community, sleep centers, and experts, we drive funding initiatives towards a deeper understanding of narcolepsy, better treatment options and ultimately a cure.